Help
Subscribe


GastroHep.com - the global online resource for all aspects of gastroenterology, hepatology and endoscopy

 21 May 2018

Advanced search
GastroHep.com - the global online resource for all aspects of gastroenterology, hepatology and endoscopy Profile of Roy Pounder

Home

News  
Journals
Review Articles
Slide Atlas
Video Clips
Online Books
Advanced Digestive Endoscopy
Classical Cases
Conference Diary
PubMed
International GH Links
USA GH Links
National GH Links
National GI Societies
Other Useful Links




Emails on Gastroenterology and Hepatology
the National AIDS Treatment Advocacy Project
Visit the gastroenterology section of the EUMS

News

Autofluorescence endoscopy improves Barrett's diagnosis

The latest Endoscopy shows that autofluorescence endoscopy vs standard 4-quadrant biopsy improves diagnostic yield for neoplasia in Barrett's esophagus.

News image

fiogf49gjkf04

The reference surveillance method in patients with Barrett's esophagus is careful endoscopic observation, with targeted as well as random 4-quadrant biopsies.

Autofluorescence endoscopy may make it easier to locate neoplasia.

Dr Borovicka and colleagues from Switzerland elucidated the diagnostic accuracy of surveillance with Autofluorescence endoscopy-guided plus 4-quadrant biopsies vs the conventional approach.

The research team enrolled a total of 187 of 200 consecutive Barrett's esophagus patients.

Of these patients, 73% were male with a mean age 67 years, who underwent endoscopy for Barrett's esophagus in 4 study centers.

In phase 1, patients were randomly assigned to either-targeted biopsy followed by 4-quadrant biopsies or conventional endoscopic surveillance with 4-quadrant biopsies.

The team excluded patients with early cancer or high-grade dysplasia, who underwent endoscopic or surgical treatment.

Autofluorescence endoscopy yielded high-grade dysplasia rates of 12%
Endoscopy

Patients who declined to participate in phase 2 of the study were also excluded.

The research team reported that 130 patients remained.

These patients were examined again with the alternative method after a mean of 10 weeks, using the same methods described.

The team's main study parameter was the detection of early cancer, adenocarcinoma or high-grade dysplasia.

The secondary aim in the second phase was the additional value of the Autofluorescence endoscopy-guided approach after conventional surveillance.

The researchers derived test accuracy measures from the first study phase.

The research team found that the Autofluorescence endoscopy yielded adenocarcinoma/high-grade dysplasia at rates of 12%.

The team noted that conventional approaches yielded adenocarcinoma/high-grade dysplasia rates of 5% on a per-patient basis.

With Autofluorescence endoscopy, previously unrecognized adenocarcinoma or high-grade dysplasia lesions were identified in 4% of the patients.

The researchers observed new lesions in 1% with the conventional approach.

Of the 19 adenocarcinoma/high-grade dysplasia lesions detected during Autofluorescence endoscopy in the first study phase, 8 were visualized.

A further 11 were only detected using untargeted 4-quadrant biopsies, giving a sensitivity of 42%.

Of the 766 biopsies classified at histology as being nonneoplastic, 58 appeared suspicious.

The specificity was 92%, with a positive predictive value of 12%, and a negative predictive value 99%.

In the second phase using Autofluorescence endoscopy, the team detected 2 further lesions in addition to the initial alternative approach in 3% of cases.

Conventional endoscopy identified only 2% of lesions.

Dr Borovicka's team concluded, “In this referral Barrett's esophagus population with a higher prevalence of neoplastic lesions, the Autofluorescence endoscopy -guided approach improved the diagnostic yield for neoplasia.”

“In comparison with the conventional approach using 4-quadrant biopsies.”

“However, Autofluorescence endoscopy alone was not suitable for replacing the standard 4-quadrant biopsy protocol.”

Endoscopy 2006: 38(9): 867-72
26 September 2006

Go to top of page Email this page Email this page to a colleague

 18 May 2018 
Esophageal dilatation in clinical practice 
 17 May 2018 
IBD and later extraintestinal manifestations
 17 May 2018 
Repeat stool DNA testing
 17 May 2018 
IBS and chronic fatigue following GI infection
 16 May 2018 
Factors associated with fecal incontinence
 16 May 2018 
Diagnostic delay in Crohn's disease
 16 May 2018 
Cardiovascular risk in diabetes mellitus with NAFLD
 15 May 2018 
Guidelines for management of Crohn's
 15 May 2018 
Hep B in the Grey Zone
 15 May 2018 
New therapies for CDI
 14 May 2018 
Blood test for the diagnosis of fibrotic NASH
 14 May 2018 
Outcomes at bariatric centers of excellence
 14 May 2018 
Management of perianal fistulas in Crohn’s
 11 May 2018 
Detection of undiagnosed celiac disease
 11 May 2018 
Alcohol consumption and drug-induced liver injury
 11 May 2018 
Depressive symptoms in IBD youth
 10 May 2018 
Post‐operative complications in elderly IBD
 10 May 2018 
Colorectal cancer screening
 10 May 2018 
Fibrosis in patients with chronic hepatitis B
 09 May 2018 
Fecal incontinence
 09 May 2018 
Health problems and IBS
 09 May 2018 
Esophageal dilatation in clinical practice 
 07 May 2018 
Omitting antibiotics in uncomplicated acute diverticulitis
 07 May 2018 
Health problems and IBS
 07 May 2018 
Assessment of diminutive colorectal polyps
 04 May 2018 
Factors associated with fecal incontinence
 04 May 2018 
National Institutes of Health workshop and obesity
 04 May 2018 
Colorectal cancer screening and ethnic inequities
 03 May 2018 
Gastrointestinal ultrasound in IBD
 03 May 2018 
PPI use and cognitive decline
 03 May 2018 
Ultransonography in postsurgical recurrence in Crohn's
 02 May 2018 
Symptom assessment in cirrhotic ascites
 02 May 2018 
Hep C antiviral treatment and liver cancer risk
 02 May 2018 
Chronic Hep B
 01 May 2018 
European guidelines on pancreatic cystic neoplasms
 01 May 2018 
Interferon‐free regimens in Hep C
 01 May 2018 
Age at IBD onset and extraintestinal complications
 30 April 2018 
Formula for preterm infants
 30 April 2018 
Primary antibiotic resistance and sequential therapy for H. pylori
 30 April 2018 
Patient-reported outcome measures in IBD trials
 27 April 2018 
Anxiety scale for chronic esophageal disease
 27 April 2018 
Disease activity in eosinophilic esophagitis
 27 April 2018 
Eastern and western practices for endoscopic resection of colorectal lesions
 26 April 2018 
Obesity and physical activity in diverticulosis
 26 April 2018 
Fecal incontinence and quality of life in IBD
 26 April 2018 
Primary sclerosing cholangitis in the USA
 25 April 2018 
Aspirin and pancreatic cancer
 25 April 2018 
Central mediators of irinotecan-induced steatohepatitis
 25 April 2018 
Neuroimaging in Hep C
 24 April 2018 
Scoring system identifies cancer risk in Barrett's
 24 April 2018 
Microbiome in athletes vs sedentary subjects
 24 April 2018 
PPI and risk of stroke
 23 April 2018 
Genome-wide study on HBV-related acute-on-chronic liver failure
 23 April 2018 
Antibody suitable for further clinical development to complement existing therapeutic strategies for HCV
 23 April 2018 
Sleep deprivation and NAFLD in the USA
 20 April 2018 
Two annexin A11 epitopes targeted by IgG1 and IgG4 autoantibodies were shared between patients with IAC/AIP and IgG4 antibodies blocked binding of IgG1 antibodies to the shared annexin A11 epitopes
 20 April 2018 
Adalimumab with azathioprine in Crohn's
 20 April 2018 
Worldwide H.pylori prevalence
 19 April 2018 
c-Myc expression and pancreatic cancer
 19 April 2018 
Olmesartan prescription in the USA

Blackwell Publishing


GastroHep.com is a Blackwell Publishing registered trademark
© 2018 Wiley-Blackwell and GastroHep.com and contributors
Privacy Statement
Disclaimer
About Us